Oramed Pharmaceuticals Inc. (NASDAQ: ORMP)
$2.3900
+0.0100 ( -0.42% ) 109.9K
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Market Data
Open
$2.3900
Previous close
$2.3800
Volume
109.9K
Market cap
$95.94M
Day range
$2.3650 - $2.4790
52 week range
$2.0000 - $3.6700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 26 | Oct 08, 2024 |
8-k | 8K-related | 14 | Sep 26, 2024 |
8-k | 8K-related | 14 | Sep 23, 2024 |
10-q | Quarterly Reports | 51 | Aug 14, 2024 |
8-k | 8K-related | 13 | Aug 02, 2024 |
8-k | 8K-related | 13 | Jun 26, 2024 |
8-k | 8K-related | 13 | Jun 24, 2024 |
3 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
ars | Annual reports | 1 | Jun 20, 2024 |